SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Kopin Corp. engages in the development, manufacture and sale of wearable technologies which include components and systems. Its portfolio includes AMLCD, LCOS displays, OLED displays, ASIC, backlights, and optical lenses. The firm uses semiconductor material technology to design, manufacture and market its component products for use in military, enterprise and consumer electronic applications, training and simulation equipment and 3D metrology equipment. The company was founded by John C.C. Fan on April 23, 1984 and is headquartered in Westborough, MA.

Kopin Corp.

Kopin Corp

Kopin Corp is surging following a new multi-million dollar defense contract and strong community buzz surrounding its pivot into AI-driven optical interconnect technology. Investors are actively tracking the stock's move toward higher price levels as they discuss its potential role in addressing data center power bottlenecks alongside the broader AI infrastructure market.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

Quantum Computing Inc. is experiencing a surge in investor interest fueled by a strong revenue beat and strategic pivots toward industrial-scale photonics and AI hardware. The community remains highly active in debating the stock's potential for a parabolic short squeeze, closely monitoring institutional accumulation and recent technological deployment milestones.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending as investors weigh strong earnings and significantly raised EBITDA guidance against ongoing geopolitical instability in the Strait of Hormuz. While some community members remain frustrated by price volatility and perceived market manipulation, others are aggressively accumulating shares, viewing the company as a long-term play on rising global LNG demand and supply chain constraints.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is experiencing high volatility as investors track rumors of a potential take-private bid by Trian Fund Management, fueling speculation about a short squeeze. The community is focused on the stock's long-term valuation, significant short interest, and international expansion plans as key catalysts to defend current levels.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing intense volatility as investors weigh conflicting narratives of aggressive hyperscaler infrastructure demand against concerns over valuation and capacity bottlenecks. The community remains deeply divided, with bulls pointing to the company's critical role in the AI data center optical upgrade cycle while bears caution that the stock's parabolic ascent and historical lack of consistent profitability signal a potential correction.

Ernexa Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.

Ernexa Therapeutics Inc.

Ernexa Therapeutics is trending due to significant momentum from positive preclinical data on its ovarian cancer treatment, which has ignited a battle between aggressive bulls targeting a breakout and skeptics focused on the company's dilution history. The community is closely watching the stock's low float and high short interest, with many traders anticipating a potential squeeze while others express caution regarding the long timeline for human clinical trials.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is at the center of heated community debate as investors weigh the company's recent achievement of closing Phase 3 of the FAA's type certification process against persistent concerns regarding cash burn and the timeline for piloted transition flights. While supporters point to strong strategic partnerships and regulatory progress as proof of a viable commercial future, critics remain focused on production speed and transparency, creating a volatile environment where sentiment shifts rapidly ahead of upcoming earnings.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

Cleanspark shares are experiencing heightened volatility as the community debates the timing of an anticipated AI infrastructure deal and its shift toward high-performance computing. While some investors are bullish on the company's power capacity and Bitcoin treasury as long-term catalysts, others are expressing frustration over the lack of a concrete hyperscale contract and the impact of recent quarterly earnings.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech100 is seeing heightened volatility and intense social media discourse driven by the looming SpaceX IPO and recent concerns regarding the validity of indirect Anthropic holdings held through special purpose vehicles. Investors remain deeply divided, with some viewing the recent price action and dilution risks as a buying opportunity ahead of potential upside, while others warn of significant overvaluation relative to the fund's net asset value.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is seeing intense retail momentum as traders draw parallels between its specialized memory chips and the massive growth seen in major semiconductor stocks. The community is actively discussing a potential gamma squeeze driven by high call option interest and the company's perceived role as a critical infrastructure player for AI and defense.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>LCID slid for a third straight day after TD Cowen and Baird trimmed their price targets following recent company updates and capital raises.</li><li>ABT dropped after cutting its 2026 EPS outlook to $5.38-$5.58 due to the impact of its $23 billion acquisition of Exact Sciences.</li><li>ASBP slumped after shareholders approved a reverse stock split and authorized additional equity issuance tied to preferred-stock conversion and financing deals.</li></ul>Shares of Lucid Group (LCID), Abbott Laboratories (ABT) and Aspire Biopharma Holdings (ASBP) dropped to fresh 52-week lows Thursday, bucking a broader market rally, as investors weighed softer growth prospects and dilution risks across the three companies.On Thursday,&nbsp;<a href="https://stocktwits.com/symbol/LCID">LCID</a> and&nbsp;<a href="https://stocktwits.com/symbol/ABT">ABT</a> shares each fell about 6%, while&nbsp;<a href="https://stocktwits.com/symbol/ASBP">ASBP</a> slumped 45%.<h2 class="st-heading-2">LCID Falls As Outlook Confidence Wavers</h2>LCID shares fell 6% on Thursday, extending their decline to a third straight session, after multiple Wall Street firms lowered price targets following recent company updates in a weaker auto market.&nbsp;Earlier this week, TD Cowen analyst Itay Michaeli cut the firm’s price target to $10 from $19 and maintained a ‘Hold’ rating, saying automakers appear better positioned than suppliers in the first quarter (Q1) to provide investors with outlook “reassurances and retaining guidance credibility.” The brokerage added that guide-down risk across the sector remains low.Baird also lowered its price target to $12 from $14 and kept a ‘Neutral’ rating after updating its model following the appointment of a permanent CEO and expansion of Lucid’s partnership with Uber.Investor sentiment has also remained under pressure from a recent $1.05 billion capital raise and a $300 million stock offering. The company is targeting production of 25,000 to 27,000 vehicles in 2026, but produced 5,500 vehicles and delivered 3,093 units in Q1 after deliveries were temporarily affected by a Gravity SUV seat-belt recall.<h2 class="st-heading-2">ABT Slides On Exact Sciences Impact To Bottomline</h2>ABT shares posted their worst session in nearly three months on Thursday after the company lowered its 2026 adjusted profit outlook due to the impact of its $23 billion acquisition of Exact Sciences.Abbott cut its full-year outlook and now expects adjusted earnings per share of $5.38 to $5.58, down from its earlier forecast of $5.55 to $5.8. Investors focused on softer organic growth trends, weakness in the nutrition segment and slower-than-expected momentum in diabetes and structural-heart devices, facing competition from Edwards Lifesciences.Evercore ISI lowered its price target to $120 from $134, saying organic growth came in “a tad below” expectations and base organic guidance was effectively reduced by about 50 basis points.However, Abbott said that the $23 billion acquisition of Exact Sciences is expected to contribute about $3 billion in incremental sales this year and support longer-term growth as Abbott continues to shift away from declining COVID testing revenue.<h2 class="st-heading-2">ASBP Slumps On Dilution Concerns</h2>ASBP shares remained under pressure after stockholders approved several proposals expanding the company’s flexibility to issue additional equity and restructure its capital base.At a special meeting earlier this month, investors approved a reverse stock split within a range of 1-for-5 to 1-for-500 and authorized the issuance of conversion shares tied to Series A preferred stock. Stockholders also approved additional equity issuance under an existing purchase agreement with Arena Business Solutions Global SPC II. A proposal to increase the authorized common shares from 490 million to 700 million was also approved.The company separately completed a preferred-stock financing tranche, generating about $10 million in proceeds, while converting part of its outstanding debt into equity, underscoring investor concerns around dilution risk and huge funding needs.Additionally, Aspire entered a letter of intent to acquire Dura Driver Control Systems in a $30 million deal to expand its footprint beyond drug delivery.<h2 class="st-heading-2">How Do Retail Traders Feel About LCID, ABT, ASBP?</h2>On Stocktwits, retail sentiment for LCID and ABT was ‘extremely bullish’ amid ‘extremely high’ message volume, while sentiment for ASBP was ‘bullish’ with ‘extremely high’ message volume.Over the past year, LCID shares have declined 67%, ABT is down 25%, and ASBP has plunged 99%.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nio-stock-outpaces-2025-gains-battery-swap-rollout-focus/cZJUf82RIx7">Nio Stock Already Outruns Last Year’s Gains — Now A Massive Battery-Swap Push Is Coming Into Spotlight</a>

In this photo illustration, the logo of Lucid Group, Inc. is displayed on a smartphone screen, with a stock market chart in the background, on May 4, 2025, in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)

LCID, ABT, ASBP Stocks Hit 52-Week Lows Today: What’s Driving The Selloff?

LCID and ABT each fell about 6% on Thursday, while ASBP plunged 45%, bucking a broader market rally.

Equity

Wealth Enhancement Advisory Services LLC Buys 18,415 Shares of Exact Sciences Corporation $EXAS

Wealth Enhancement Advisory Services LLC increased its stake in Exact Sciences Corporation (NASDAQ:EXAS - Free Report) by 24.7% in the fourth quarter, according to the company in its most recent...

Syquant Capital Sas Acquires Shares of 92,010 Exact Sciences Corporation $EXAS

Syquant Capital Sas bought a new position in shares of Exact Sciences Corporation (NASDAQ:EXAS - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 92,010 shares of the medica...

Promising Medical Stocks To Follow Now - March 24th

Exact Sciences, Eli Lilly and Company, UnitedHealth Group, Johnson & Johnson, and ImmunityBio are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks...

Exact Sciences' (EXAS) "Neutral" Rating Reaffirmed at BTIG Research

BTIG Research restated a "neutral" rating on shares of Exact Sciences in a research report on Tuesday...

Exact Sciences (NASDAQ:EXAS) Sets New 12-Month High  - Time to Buy?

Exact Sciences (NASDAQ:EXAS) Hits New 12-Month High - What's Next...

Medical Stocks To Research - March 23rd

Exact Sciences, UnitedHealth Group, and Eli Lilly and Company are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies whose primary business is the development, manufacture, distribution, or provision of heal...

Marshall Financial Group LLC Purchases Shares of 17,663 Exact Sciences Corporation $EXAS

Marshall Financial Group LLC acquired a new stake in shares of Exact Sciences Corporation (NASDAQ:EXAS - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 17,663 shares of t...

Promising Medical Stocks To Research - March 20th

UnitedHealth Group, Eli Lilly and Company, Johnson & Johnson, Exact Sciences, Merck & Co., Inc., AbbVie, and Amgen are the seven Medical stocks to watch today, according to MarketBeat's stock...

Exact Sciences (NASDAQ:EXAS) Sees Unusually-High Trading Volume  - Time to Buy?

Exact Sciences (NASDAQ:EXAS) Sees Large Volume Increase - Time to Buy...

EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

EXAS
Exact Sciences Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

Latest EXAS News

EXASExact Sciences Corp.